Vickie & Jack Farber
Vision Research Center at Wills Eye
Advancing Science • Fostering Collaboration • Inspiring Innovation
Shortcodes Ultimate
Open Clinical Trials
A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles plus Patching for Amblyopia in Children 3 to 13 Years Old (ATS22)
PI: Kammi Gunton, MD
Description:
Amblyopia (sometimes called “lazy eye”) is one of the most common causes of permanent decreased vision in children. The purpose of this study is to find out if treating amblyopia with glasses and patching at the same time improves vision as well as treating amblyopia first with glasses and then with patching, if needed.
The study is being conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and is supported through funding from the National Eye Institute of the U.S. National Institutes of Health.
You will be asked to be in the study for about 56 weeks. The study will involve either wearing glasses and a patch at the same time or first wearing glasses before starting to wear a patch (if needed). You will see your eye doctor about every 8 weeks for 56 weeks. At each visit, you will have your eyes examined and your vision tested.
If you take part in the study, you will receive up to $400 for your participation. These payments will be paid as follows: $40 for each completed visit (up to ten visits) by Amazon gift card.
Clinical Study Coordinator: Kieran Alessi, kalessi@willseye.org
A Randomized Trial of Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age (ATS23)
PI: Kammi Gunton, MD
Description:
This study is being done to evaluate treatment for amblyopia. Amblyopia is the loss of the ability to see clearly through one eye. The brain may start to ignore the image from the weaker eye. Amblyopia is also called "lazy eye." It is the most common cause of vision problems in children. About 238 children will be in this study at about 65 sites in the US and 5 sites outside of the US. You will be asked to be in this research study for about 26 weeks.
The study will involve you wearing your glasses (if you need them) and then being randomized to wearing either a patch or to using the Luminopia virtual reality headset. You will see your eye doctor at 13 weeks and 26 weeks. Wireless internet is needed to use the Luminopia headset. If you do not have access to the internet in your home, the study will lend a Hotspot to you to be used only for the study device.
If you take part in the study, you will receive up to $500 for your participation.
Clinical Study Coordinator: Kieran Alessi, kalessi@willseye.org